RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma

Bo Zhao(The Wistar Institute)
Journal of Experimental & Clinical Cancer Research
September 15, 2022
10.1186/s13046-022-02490-3
Cited by 15

Related Papers

ARID1A promotes genomic stability through protecting telomere cohesion
|Nature Communications|2019|64
Topoisomerase 1 cleavage complex enables pattern recognition and inflammation during senescence
|Nature Communications|2020|63
RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma
|Research Square|2022|0